RU2001132735A - SOLID MEDICINAL FORM BASED ON CARVEDILOL - Google Patents

SOLID MEDICINAL FORM BASED ON CARVEDILOL

Info

Publication number
RU2001132735A
RU2001132735A RU2001132735/15A RU2001132735A RU2001132735A RU 2001132735 A RU2001132735 A RU 2001132735A RU 2001132735/15 A RU2001132735/15 A RU 2001132735/15A RU 2001132735 A RU2001132735 A RU 2001132735A RU 2001132735 A RU2001132735 A RU 2001132735A
Authority
RU
Russia
Prior art keywords
dosage form
solid dosage
carvedilol
form according
saccharide
Prior art date
Application number
RU2001132735/15A
Other languages
Russian (ru)
Other versions
RU2214243C2 (en
Original Assignee
Открытое акционерное общество "Химико-фармацевтический комбинат "Акрихин"
Filing date
Publication date
Application filed by Открытое акционерное общество "Химико-фармацевтический комбинат "Акрихин" filed Critical Открытое акционерное общество "Химико-фармацевтический комбинат "Акрихин"
Priority to RU2001132735A priority Critical patent/RU2214243C2/en
Priority claimed from RU2001132735A external-priority patent/RU2214243C2/en
Application granted granted Critical
Publication of RU2214243C2 publication Critical patent/RU2214243C2/en
Publication of RU2001132735A publication Critical patent/RU2001132735A/en

Links

Claims (6)

1. Твердая лекарственная форма, содержащая в качестве действующего вещества карведилол и в качестве фармацевтически приемлемых вспомогательных веществ сахарид, крахмал, стеариновую кислоту и/или ее соль при следующем соотношении ингредиентов, мас.%:1. A solid dosage form containing carvedilol as active ingredient and pharmaceutically acceptable excipients, saccharide, starch, stearic acid and / or its salt in the following ratio of ingredients, wt.%: Карведилол 1,0-25,0Carvedilol 1.0-25.0 Крахмал 0,1-3,5Starch 0.1-3.5 Сахарид 70,0-96,9Saccharide 70.0-96.9 Кислота стеариноваяStearic acid и/или ее соль 0,6-1,5and / or its salt 0.6-1.5 2. Твердая лекарственная форма по п.1, отличающаяся тем, что содержит в качестве соли стеариновой кислоты стеарат кальция или магния.2. The solid dosage form according to claim 1, characterized in that it contains calcium or magnesium stearate as the salt of stearic acid. 3. Твердая лекарственная форма по п.1, отличающаяся тем, что содержит в качестве сахарида маннит или лактозу.3. The solid dosage form according to claim 1, characterized in that it contains mannitol or lactose as a saccharide. 4. Твердая лекарственная форма по п.1, отличающаяся тем, что содержит в качестве сахарида модифицированную лактозу.4. The solid dosage form according to claim 1, characterized in that it contains modified lactose as a saccharide. 5. Твердая лекарственная форма по пп.1-4, отличающаяся тем, что содержит в качестве крахмала модифицированный крахмал.5. The solid dosage form according to claims 1 to 4, characterized in that it contains modified starch as starch. 6. Твердая лекарственная форма по любому из пп.1-5, отличающаяся тем, что выполнена в форме таблетки.6. A solid dosage form according to any one of claims 1 to 5, characterized in that it is made in the form of a tablet.
RU2001132735A 2001-12-05 2001-12-05 Carvedilol-base solid medicinal form RU2214243C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2001132735A RU2214243C2 (en) 2001-12-05 2001-12-05 Carvedilol-base solid medicinal form

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2001132735A RU2214243C2 (en) 2001-12-05 2001-12-05 Carvedilol-base solid medicinal form

Publications (2)

Publication Number Publication Date
RU2214243C2 RU2214243C2 (en) 2003-10-20
RU2001132735A true RU2001132735A (en) 2004-04-20

Family

ID=31988543

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2001132735A RU2214243C2 (en) 2001-12-05 2001-12-05 Carvedilol-base solid medicinal form

Country Status (1)

Country Link
RU (1) RU2214243C2 (en)

Similar Documents

Publication Publication Date Title
CA2311734C (en) Flash-melt oral dosage formulation
CA2326517A1 (en) New galenic preparations of meloxicam for oral administration
CA2427815A1 (en) Controlled release hydrocodone formulations
MY129234A (en) Oral pharmaceutical forms of administration with a delayed action with tramadol.
EA200400471A1 (en) ORAL DOSED FORM PROPIVERINA
WO2004000197A3 (en) Quick dissolve compositions and tablets based thereon
RU96118271A (en) COMPOSITIONS CONTAINING FINE-CREATED NEBIVOL
WO1998009597A3 (en) Cushioning beads and tablet comprising the same capable of forming a suspension
RU96116411A (en) QUICKLY DISPERSABLE READY-FORMED DRUG FORM TRAMADOL OR TRAMADOL SALT
RU2003100507A (en) PHARMACEUTICAL COMPOSITIONS
IS7006A (en) Dihydrogen 3-piperidinopropiophenone and medicinal products containing said compounds
JP2006232675A (en) Complex type solid preparation for dissolution in oral cavity
HUP0301390A2 (en) Oral pharmaceutical composition containing valsartan
RU2000130202A (en) ORAL DOSAGE FORMS WITH REPRODUCABLE INDICATORS OF RELEASE OF THE ACTIVE SUBSTANCE OF HATIFLOXACIN OR ITS PHARMACEUTICALLY ACCEPTABLE SALTS OR HYDRATES
KR900004326A (en) Dispersible tablets of dihydrogergotoxin and its acid addition salt
CA2353693A1 (en) Pharmaceutical composition containing citalopram
HUP0203148A2 (en) Orally distintegrating composition comprising mirtazapine
WO2004071156A3 (en) Use of edible acid in fast-dispersing pharmaceutical solid dosage forms
RU2001132735A (en) SOLID MEDICINAL FORM BASED ON CARVEDILOL
BE2016C017I2 (en)
CA2120001A1 (en) Flavopereirine-based pharmaceutical composition and use thereof for treating hiv
JP2006206465A (en) Sustainable solid pharmaceutical preparation dissolving in oral cavity
RU2003132049A (en) PHARMACEUTICAL COMPOSITION Possessing Cerebrovasodilating and Nootropic Activity
RU2004104603A (en) ANTIFUNGAL PHARMACEUTICAL COMPOSITION
RU2000115604A (en) COMPOSITION OF ANTIBACTERIAL MEDICINE